State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders

The Maryland Legislature approved file SB562 ("State Board of Pharmacy - Prescriber-Pharmacist Agreements - Treatment of Opioid Use Disorders"), by a recorded vote of 177 to 0. Last action: April 14, 2026.

Maryland file SB562, before the Maryland Legislature. Passed as of 2026-04-14.

Official summary

Official synopsis: Authorizing licensed certified midwives to enter into therapy management contracts; repealing a requirement that authorized prescribers submit prescriber-pharmacist agreements to the health occupations board that regulates the authorized prescriber; authorizing pharmacists, under certain circumstances, to enter into prescriber-pharmacist agreements that authorize the pharmacist to treat an opioid use disorder using controlled dangerous substances drug therapy; etc.

How they voted

Yes (177)

Did not vote / other (11)

Read the official record for SB562

See everything up for a vote · This week in Maryland · See what we have filed with the clerk